Deciphering the potential molecular mechanism of resmetirom in idiosyncratic drug- induced autoimmune hepatitis using network toxicology and molecular docking

Key Points

• Resmetirom affects molecular mechanisms crucial for autoimmune hepatitis treatment, promoting understanding of its therapeutic potential.
• Key evidence shows resmetirom's interaction with specific molecular targets, enhancing its role in autoimmune hepatitis management.
• Analysis utilizing network toxicology combined with molecular docking provides insights into drug interactions at the molecular level.
• This work highlights the need for further exploration in clinical settings to confirm these findings and evaluate drug safety.